-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
5- FU treated organoids
Study
EGAS00001003592
-
cfDNA dataset from extracelular vesicles and paired non-fractionated samples
Study
EGAS00001006848
-
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
Study
EGAS50000000347
-
A mathematical model of cell-free DNA fragment size reveals cancer-specific fragmentomic patterns
Study
EGAS50000001560
-
Targeted_NanoSeq_Buccal
Study
EGAS00001005925
-
Multisite_Breast_Cancer_Whole_Genome
Study
EGAS00001000890
-
SCANDARE HNSCC
Study
EGAS50000001158
-
GENOMIC INSTABILITY IN MISMATCH REPAIR DEFICIENT COLORECTAL CANCER
Study
EGAS00001002477
-
Mesothelioma_Whole_Genomes
Study
EGAS00001000830